Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome
JavaScript is disabled for your browser. Some features of this site may not work without it.
Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome
Edem Efe; Kocayiğit, İbrahim; Pabuccu Mustafa Turker; Kucukukur Murat; Alpaslan Erkan; Tas Sedat; Cil Alper; Aksoy Murat Necati; Vural, Mustafa Gökhan; Akdeniz Bahri
Conclusions: We suggest that more attention should be paid to the PLR values of these patients on admission to identify individuals who may not benefit from clopidogrel during the course of ACS.